Stocktoria
FILANA THERAPEUTICS, INC. FLNA
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2000-07-14
FILANA THERAPEUTICS, INC. financials (annual)
Bars are annual figures from 2017 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| R&D expense | $26.6M | $69.6M | $89.4M | $68.0M | — | $24.8M | — | — | $3.0M | $7.6M |
| Operating income | -$95.4M | -$141.4M | -$106.0M | -$80.0M | — | -$32.9M | -$6.4M | -$5.0M | -$6.7M | -$11.9M |
| Income tax | $0 | $0 | — | — | $0 | — | — | — | — | — |
| Net income | -$91.0M | -$24.3M | -$97.2M | -$76.2M | — | -$32.4M | -$6.3M | -$4.6M | -$6.6M | -$11.9M |
| EPS (diluted) | $-1.88 | $-1.46 | $-2.32 | $-1.90 | — | — | — | — | — | — |
| Operating cash flow | -$32.3M | -$116.9M | -$82.0M | -$77.5M | — | -$30.2M | -$5.4M | -$2.5M | -$4.8M | -$8.2M |
| Free cash flow | -$32.8M | -$117.0M | -$82.4M | -$80.2M | — | -$52.4M | — | -$2.5M | — | — |
| Cash & equivalents | $95.5M | $128.6M | $121.1M | $201.0M | $174.7M | $233.4M | $93.5M | $23.1M | $19.8M | $10.5M |
| Total assets | $118.4M | $157.5M | $151.7M | $234.8M | $207.3M | $266.8M | $94.3M | $23.5M | $20.1M | $10.8M |
| Total liabilities | $44.0M | $11.8M | $14.2M | $7.3M | $8.6M | $12.9M | $2.1M | $1.4M | $511,000 | $1.1M |
| Shareholders' equity | $74.4M | $145.7M | $137.5M | $227.5M | $198.7M | $253.9M | $92.2M | $22.1M | $19.6M | $9.7M |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.